• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 2X40G; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 2X40G; BONE CEMENT, ANTIBIOTIC Back to Search Results
Catalog Number 4003940002
Device Problems Naturally Worn (2988); Therapeutic or Diagnostic Output Failure (3023); Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problems Failure of Implant (1924); Unspecified Infection (1930)
Event Date 06/11/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Concomitant medical products: item number: 00598605702; item name : non-augmentable stemmed tibial component option size 8; item batch: 62133498; handled in (b)(4); item number: 00596401751; item name: femoral component option size g left; item batch: 62254530; handled in (b)(4); item number: 00596405010; item name: articular surface size gh 10 mm height; item batch: 62412557; handled in (b)(4); item number: 00597206538; item name: all poly patella size 38 mm dia.Standard 9.5 mm thickness; item batch: 62413073; handled in (b)(4).Report source, foreign - event occurred in (b)(6).Customer has indicated that the product will not be returned to zimmer biomet for investigation.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.Root cause was unable to be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It has been reported that it has been reported that a revision due to infection was performed following a total left knee replacement on (b)(6) 2018, and a spacer k and 4 grams of vancomycin with cement was placed during this revision surgery.The second stage revision was planned on (b)(6) 2018 to remove the spacer and to place the implant.It was noticed an implant loosening with evidence of wear of the polyethylene insert and evidence of device pitting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 2X40G
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
hélène bataille
plateau de lautagne bp75
valence 26903
FR   26903
0334757591
MDR Report Key8404240
MDR Text Key138251317
Report Number3006946279-2019-00169
Device Sequence Number1
Product Code MBB
UDI-Device Identifier07350023774130
UDI-Public(01)07350023774130
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date07/31/2015
Device Catalogue Number4003940002
Device Lot Number235BAE2108
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received06/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/10/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-